The Possible Mechanism of Interaction between Xanthines and Quinolone
- 1 November 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 42 (11) , 767-772
- https://doi.org/10.1111/j.2042-7158.1990.tb07018.x
Abstract
To clarify the mechanism of interaction between theophylline and enoxacin, the effects of enoxacin and its metabolite, 4-oxo-enoxacin, on the disposition of new xanthine derivatives, 1-methyl-3-propylxanthine (MPX) and 3-propylxanthine (enprofylline), as models of theophylline have been investigated in rats. Pretreatment with enoxacin significantly delayed the elimination of MPX from plasma. No significant change in the volume of distribution of MPX was observed in the presence of enoxacin, but the total body clearance of MPX was significantly decreased by approximately 60 and 80% after pretreatment with 25 and 100 mg kg−1 of enoxacin, respectively. The amount of the decrease in total body clearance depended on the dose of enoxacin. 4-Oxo-enoxacin had little or no effect on MPX disposition. A newly developed quinolone, NY-198, which does not affect the disposition of theophylline, also did not affect the disposition of MPX. Enoxacin also had no effect on the disposition of enprofylline. These results indicate that the mechanism for decrease in theophylline clearance induced by enoxacin may not be due to its metabolite, 4-oxo-enoxacin, but to enoxacin itself, and that enoxacin does not inhibit solely the elimination process depending on cytochrome P450 isoenzyme for N-demethylation. It is likely that enoxacin has no influence on the renal excretion of xanthines.This publication has 30 references indexed in Scilit:
- Effect of quinolones on caffeine dispositionClinical Pharmacology & Therapeutics, 1989
- Evaluation of the effect of norfloxacin on the pharmacokinetics of theophyllineClinical Pharmacology & Therapeutics, 1988
- 4-quinolones inhibit biotransformation of caffeineEuropean Journal of Clinical Pharmacology, 1988
- Studies on Alkyl-Xanthine Derivatives II. Pharmacokinetic and Pharmacodynamic Studies of a New Bronchodilator, 1-Methyl-3-Propylxanthine (MPX)The Japanese Journal of Pharmacology, 1988
- Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effectsAntimicrobial Agents and Chemotherapy, 1987
- Enoxacin ? a potent inhibitor of theophylline metabolismEuropean Journal of Clinical Pharmacology, 1987
- Effects of probenecid on enprofylline kinetics in manEuropean Journal of Clinical Pharmacology, 1986
- Differential effects of cimetidine on theophylline metabolic pathwaysEuropean Journal of Clinical Pharmacology, 1984
- Cigarette smoking and theophyiiine clearance and metabolismClinical Pharmacology & Therapeutics, 1981
- Noncompartmental Determination of the Steady‐State Volume of DistributionJournal of Pharmaceutical Sciences, 1979